Objective: To determine the impact of surgical site infections (SSIs) on health care costs following common ambulatory surgical procedures throughout the cost distribution. Background: Data on costs of SSIs following ambulatory surgery are sparse, particularly variation beyond just mean costs. Methods: We performed a retrospective cohort study of persons undergoing cholecystectomy, breast-conserving surgery, anterior cruciate ligament reconstruction, and hernia repair from December 31, 2004 to December 31, 2010 using commercial insurer claims data. SSIs within 90 days post-procedure were identified; infections during a hospitalization or requiring surgery were considered serious. We used quantile regression, controlling for patient, operative, and postoperative factors to examine the impact of SSIs on 180-day health care costs throughout the cost distribution. Results: The incidence of serious and nonserious SSIs was 0.8% and 0.2%, respectively, after 21,062 anterior cruciate ligament reconstruction, 0.5% and 0.3% after 57,750 cholecystectomy, 0.6% and 0.5% after 60,681 hernia, and 0.8% and 0.8% after 42,489 breast-conserving surgery procedures. Serious SSIs were associated with significantly higher costs than nonserious SSIs for all 4 procedures throughout the cost distribution. The attributable cost of serious SSIs increased for both cholecystectomy and hernia repair as the quantile of total costs increased ($38,410 for cholecystectomy with serious SSI vs no SSI at the 70th percentile of costs, up to $89,371 at the 90th percentile). Conclusions: SSIs, particularly serious infections resulting in hospitalization or surgical treatment, were associated with significantly increased health care costs after 4 common surgical procedures. Quantile regression illustrated the differential effect of serious SSIs on health care costs at the upper end of the cost distribution.
I
nfections are one of the most common complications after surgical procedures and a significant cause of morbidity. Surgical site infections (SSIs) account for over 20% of hospital-acquired infections and are the most common reason for unplanned hospital readmission after operation. [1] [2] [3] SSIs can prolong hospital stays by as much as 7 to 11 days and are estimated to result in annual costs of $3.5 billion or more in the US. 2 Numerous estimates are available for the health care costs attributable to SSIs per patient; a recent meta analysis reported inpatient hospital costs due to SSIs of $20,875 (2012 US Dollars (USD)). However, this cost estimate does not take into account additional health care costs due to SSI, including costs for physician care, laboratory, radiology, and outpatient antibiotics. In addition, the reported summary cost attributable to SSIs does not take into account variation in attributable costs depending on the type of surgery. Reported costs of SSIs have ranged from a low of $3173 after cesarean section to $28,790 after coronary artery bypass surgery (adjusted to 2012 $US). [4] [5] [6] In general, the costs of SSIs described in the literature have been highest for neurologic, cardiac, and orthopedic operations, and lowest for less-extensive operations such as breast surgery and cesarean section, in which the majority of SSIs are superficial rather than deep or organ-space. 4, 5, [7] [8] [9] [10] Even fewer data are available on the costs of SSIs following procedures performed in ambulatory settings, either in freestanding facilities or hospital-affiliated outpatient centers. Ambulatory surgery accounts for a growing proportion of surgical procedures, although the proportion performed as outpatient surgery varies by surgical specialty. 11, 12 In a recent study, Hollingsworth et al 12 found that the likelihood to perform operations in outpatient surgery was higher for orthopedic, urologic, and gastroenterology compared to other surgical specialties, and the proportion of these procedures performed as outpatients increased over time.
Rhee et al 13 reported comprehensive surveillance for SSIs after ambulatory surgery using medical claims data and validation with medical record review. They found rates of SSIs ranging from 0.5% for cholecystectomy, 0.7% after anterior cruciate ligament (ACL) reconstruction, 1.3% for hernia repair, to 3.2% after appendectomy. Deep SSI rates after a variety of orthopedic surgeries performed by the same surgeons ranged from 0.4% to 0.8% depending on whether operations were performed in a multispecialty ambulatory surgery center (ASC) or a dedicated orthopedic ASC.
14 In 2 studies of ambulatory surgeries, 0.6% of lumbar discectomies 15 and 0.2% of thyroidectomies 16 were
From the
METHODS
We conducted a retrospective cohort study using the HealthCore Integrated Research Database SM , with longitudinal claims data from 13 Anthem-owned Blue Cross and/or Blue Shield health plans located in the Southeast, Mid-Atlantic, Eastern, Central, and Western US regions. Data included all fully adjudicated claims submitted for reimbursement from providers, facilities, and outpatient pharmacies linked to health plan enrollment information.
Fully insured members enrolled in a fee-for-service health plan including medical coverage of hospital and physician services and prescription drug coverage were eligible for inclusion into the cohort. To assess comorbid conditions and capture costs, we required members to have insurance coverage from 365 days before surgery through 180 days after surgery. To avoid censoring, we excluded patients who died within 180 days of surgery. Medical claims were restricted to paid claims.
Patient Populations
We identified cholecystectomy, BCS, ACL reconstruction, and hernia repair procedures performed from December 31, 2004 to December 31, 2010 in members eligible for cohort entry using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and Current Procedural Terminology, 4th edition (CPT-4) procedure codes from inpatient and ambulatory facilities (other than home health agencies) and provider claims (Supplemental Digital Content 1). We included members aged from 18 to 64 years for BCS and cholecystectomy and members aged 6 months to 64 years for ACL reconstruction and hernia repair.
Patients were excluded for any of the following reasons, as defined previously [17] [18] [19] : no other supporting evidence for the surgery (eg, surgery coded by provider-or facility-only and no CPT-4 codes for anesthesia, pathology, surgery revenue codes), additional procedures performed at the same time as the eligible surgery, medically complicated patient, ICD-9-CM diagnosis code or prescription claim indicating HIV-positive status, history of organ transplant in the previous year (ICD-9-CM V42.0-V42.1, V42.6-V42.7, V42.81-V42.84), preexisting SSI within 30 days before the surgical procedure, and cholecystectomy or hernia repair with discordant provider and facility coding for approach (laparoscopic vs open) or anatomic site. We restricted analyses to the first surgical procedure per patient, per procedure type.
Identification of SSIs
SSIs first recorded 2 to 90 days after surgical procedures were identified using ICD-9-CM diagnosis codes from inpatient and outpatient facilities and provider claims (Supplemental Digital Content 2-4). We excluded claims with locations inconsistent with a provider diagnosis (eg, laboratory, patient's home) and claims with CPT-4 codes for laboratory services (88104-88399), because the diagnosis codes on those lines may have been used for ''rule-out'' diagnoses. [17] [18] [19] We censored the observation period to avoid misclassification of SSIs after a subsequent surgery using the National Healthcare Safety Network procedure list. 20 We defined serious SSI as infection coded during an inpatient hospitalization (index hospitalization or readmission) or requiring surgical treatment within 90 days of the index procedure. Surgical treatment included all ICD-9-CM and CPT-4 procedure codes in Supplemental Digital Content 2-4 (except ICD-9-CM procedure 85.91, 86.01, and 86.28 for BCS), and laparotomy codes for hernia repair and cholecystectomy (ICD-9-CM procedure 54.11, 54.12, 54.19; CPT-4 49000, 49002). All other SSIs were categorized as nonserious.
Outcomes and Covariates
The primary outcome was total medical costs, defined as the total allowed amount for all medical and pharmacy claims (ie, sum of patient-and plan-paid amounts) from the surgery date through 180 days after surgery. For statistical analyses, all costs were inflation adjusted to 2014 USD using the medical care component of the Consumer Price Index. 21 Natural log transformed total costs were used as the dependent variable for all models.
We selected a set of potential confounders that might influence the relationship between health care costs and SSI, including patient demographics, comorbid conditions, medications, type of facility, operative factors, and postoperative factors ( Table 1) . We used the American Hospital Association Annual Survey of Hospitals (Health Forum, LLC, Chicago, IL) and the Outpatient Surgery Center Profiling Solution data (IMS Health, Plymouth Meeting, PA) to determine whether the surgical procedure was performed at a hospital or freestanding ASC. The facility information from these 2 data sources was matched to the operative facility using National Provider Identifier codes, where available; otherwise matching was performed using facility name and address fields. Among facilities matching to an American Hospital Association hospital, we used an inpatient designation in the claims data to define whether the procedure was performed as an inpatient or outpatient.
Statistical Analysis
An ordinary least squares (OLS) model was used to identify covariates for inclusion in a quantile regression model of total medical costs, with serious and nonserious SSI as the primary exposures. Backward stepwise variable selection was used with cut off values of P < 0.10 for entry and P < 0.15 for retention. Model fit diagnostics and collinearity were assessed.
Quantile regression was used to estimate the conditional percentiles of total cost and association with SSI, including the significant covariates identified in the OLS model. The quantile regression technique was chosen for the analyses because it enables assessment of the effects of a covariate on all parts of the cost distribution (ie, upper, lower, and median) rather than only the mean, as with OLS. 22, 23 The 95% confidence intervals were approximated by bootstrapping with 500 repetitions. Quantile regression for costs was performed at the intervals of 10% for percentiles from 10% up to 90%, and for the 25% and 75% percentiles. Interquantile regression analysis was performed for 3 interquantile ranges: 10th to 90th, 10th to 50th, and 50th to 90th quantile. Attributable costs of nonserious and serious SSIs were determined by using total costs rather than the natural log of total costs as the dependent variable in the quantile regression models. All data management and analyses were performed in SAS version 9.3 (SAS Institute Inc, Cary, NC) and Stata version 13 (StataCorp LP, College Station, TX).
RESULTS
Among the eligible patients included in analyses, 21,062 had an ACL reconstruction; 57,750 had a cholecystectomy; 60,681 had a hernia repair procedure; and 42,489 had BCS (Table 2 ). Among patients with ACL reconstruction, 40.9% of patients were female with a median age of 30 years. Females made up 74.6% of patients in the cholecystectomy cohort (median age 45 yrs), and 20.1% in the hernia repair cohort (median age 48 yrs). The median age of women in the BCS cohort was 49 years. Thirty-three percent of patients in the ACL cohort had surgery performed in an ASC. In contrast, the majority of cholecystectomy, hernia repair, and BCS procedures were performed as outpatient surgeries in a hospital. One-quarter of cholecystectomy procedures were performed during an inpatient hospitalization ( Table 2 ). The procedures with missing facility information varied significantly with regard to demographics and operative factors compared to facilities with known facility association (data not shown), consistent with missing facilities comprising a mixture of freestanding ASC, outpatient surgery, and inpatient hospitals.
The incidence of serious and nonserious SSIs by procedure type is shown in Table 2 . The overall incidence of SSI varied from 0.7% after cholecystectomy to 1.6% after BCS, and the proportion classified as serious ranged from 50% after BCS to 80% after ACL reconstruction. Fifty-six percent of SSIs after ACL reconstruction resulted in reoperation during an inpatient hospitalization, compared to 10.7% of the serious SSIs after BCS. Approximately 20% of serious SSIs after both cholecystectomy and hernia repair resulted in reoperation during an inpatient hospitalization. An additional 59.4% of serious SSIs after cholecystectomy and 48.2% of serious SSIs after hernia repair were categorized as ''serious'' because of medical treatment (other than reoperation) during an inpatient hospitalization ( Table 2) . Histograms of the unadjusted total medical costs for the 4 procedures are shown in Figure 1 , stratified by SSI. The cost distribution shifted to the right in patients with nonserious SSI and serious SSI within 90 days of surgery, compared to patients without SSI.
In quantile regression models at the 50th percentile, SSI was associated with higher median costs after controlling for underlying health conditions, age, sex, operative variables, and facility type, although the magnitude varied depending on the seriousness of the SSI and by procedure (Table 3) . Serious SSIs were associated with significantly higher costs compared with nonserious SSIs; the parameter estimate for serious SSI was almost 5-fold higher than for nonserious SSI for cholecystectomy, 3-fold higher for ACL reconstruction and hernia repair (all P < 0.001), and 2-fold higher for BCS (P ¼ 0.005). Compared with outpatient hospital facilities, inpatient hospital procedures were associated with higher costs for all 4 procedures. Freestanding ASCs were associated with significantly lower costs compared with outpatient hospital facilities for all 4 procedures, with the greatest impact observed for hernia repair (Table  3) . Other factors associated with significantly higher median costs included a number of underlying conditions (eg, peripheral vascular disease, diabetes, psychoses, depression, malnutrition or previous weight loss, treatment with disease-modifying antirheumatic drugs or biologic agents). Factors significantly associated with costs that were unique to individual surgical procedures included choledocholithiasis and combinations of surgical approach/acute cholecystitis (cholecystectomy), anatomic site and laparoscopic approach (hernia repair), and highest cancer stage, concurrent lymph node removal, and number of re-excisions (BCS).
The attributable median costs of infection were significantly higher for serious versus nonserious SSIs after all surgical procedures: 5-fold higher for ACL reconstruction ($19,356 vs $3,735), 10-fold higher for cholecystectomy ($21,451 vs $2,219), 5-fold higher for hernia repair ($16,489 vs $3,028), and 3-fold higher for serious versus nonserious SSI after BCS ($6,959 vs $2,425) ( Table 4 ). The attributable costs of both nonserious and serious SSIs increased from the 10th to the 90th percentile of total costs ( Table 4) . The graphs displayed in Figure 2 plot the attributable costs for nonserious and serious SSIs across the percentile distribution of total costs for the 4 surgical procedures, controlling for all covariates. The attributable costs for both nonserious and serious SSIs after ACL reconstruction increased 6-fold from the 10th to the 90th percentiles of the cost distribution ( Fig. 2 and Table 4 ). A 6-fold increase in attributable costs for nonserious SSIs from the 10th to the 90th percentile was seen in the BCS cohort, with a 5-fold increase in attributable costs of serious SSIs. The attributable costs after cholecystectomy increased 4-fold for nonserious SSIs and 15-fold for serious SSIs, whereas the attributable costs of nonserious SSIs increased 7-fold and 11-fold for serious SSIs after hernia repair from the 10 th to the 90 th percentiles. Overall, the attributable costs of both nonserious and serious SSIs were lower after BCS than for the other 3 surgery types.
Interquantile regression was used to quantify the cost differences of nonserious and serious SSIs at different points of the cost distribution (Table 5 ). For BCS and ACL reconstruction, the parameter estimates for nonserious and serious SSIs were not significant in any of the 3 interquantile models, indicating that costs attributable to serious versus nonserious SSIs did not vary significantly between the tested quantiles. For cholecystectomy and hernia repair, the parameter estimates for nonserious SSIs were not significant in any of the 3 interquantile models; however, the parameter estimates for serious SSIs were significant in all models, indicating significantly increased attributable costs of serious SSIs between the tested quantiles. Correspondingly, the proportion of serious SSIs resulting in reoperation during an inpatient hospitalization was highest in the highest decile for both cholecystectomy and hernia repair (27%), and the proportion diagnosed and treated during an inpatient hospitalization (without reoperation) was higher for both procedures beginning with the 80th percentile and above (59%-69% for cholecystectomy, 34%-58% for hernia repair) compared with lower deciles in the cost distribution.
DISCUSSION
In this observational study of persons undergoing 4 common ambulatory surgical procedures, SSIs were associated with significantly increased total health care costs. Serious SSIs were associated with greater costs than nonserious SSIs for all 4 procedures, which, to our knowledge, has not been previously reported. In addition, we found differences in costs of SSIs across the distribution of total costs by the use of quantile regression, which is not generally examined in studies of costs due to infection.
Most prior studies of costs of SSIs reported single cost estimates without discriminating between serious and nonserious SSIs. Recently, Schweizer et al 10 reported attributable costs of approximately $7,000 for superficial versus $25,700 for deep SSIs, but these estimates were calculated for a mixed group of surgical procedures. We found significant differences in costs for nonserious and serious SSIs within quantiles for all 4 procedure types, including median attributable costs. This is especially important because the proportion of SSIs that required hospitalization or surgical treatment (which we termed ''serious'') varied by procedure from 50% after BCS compared with 80% after ACL reconstruction.
The difference we found in attributable costs between serious and nonserious SSIs was smallest for BCS. The vast majority of SSIs after BCS are superficial, involving only skin and soft tissue. 24 This is consistent with our finding that the proportion of ''serious'' infections resulting in reoperation during an inpatient hospitalization after BCS was very small (10.7%), and almost 50% of the ''serious'' 
<0.001
Coeff indicates coefficient estimate; ref, reference group; std err, standard error.
Ã
Models were adjusted for all variables retained in the ordinary least squares regression model; only select parameters shown here. yNot included in the model because it did not meet the requirement for retention in ordinary least squares regression.
zFemale not included because the BCS model was restricted to females.
SSIs were categorized as such based on a wound care procedure performed outside of the operating room (ie, in a clinic or at the bedside). In contrast, as we reported previously the majority of SSIs after ACL reconstruction were coded for septic arthritis, 18 which would be expected to result in high costs because of the need for prolonged intravenous antibiotics and surgical treatment, often leading to removal of ligament allografts and subsequent revision surgery. In our cohort, 56% of the serious SSIs after ACL reconstruction required surgical treatment in the operating room during an inpatient hospitalization. Serious SSIs after hernia repair and cholecystectomy were likely associated with higher costs because of the need for inpatient hospitalization in the majority and abdominal surgery in about 20% of cases, presumably to drain abdominal abscesses and debride devitalized tissue. For all of the surgical procedures we studied, there was no significant variation in costs of nonserious SSIs across the distribution of total costs, although nonserious SSIs still resulted in significantly increased costs compared to uninfected individuals. Treatment of nonserious infections would likely have involved only outpatient office visits and oral antibiotics (since inpatient hospitalization was incorporated in our definition of serious SSI). For both hernia repair and cholecystectomy, the costs of serious SSIs increased significantly at the higher end of the cost distribution. For both of these procedures, the proportion of serious SSIs diagnosed and treated during an inpatient hospitalization was much higher at the upper (!80%) than at the lower end of the cost distribution, and the proportion of serious SSIs resulting in reoperation was highest in the 2 highest deciles. Thus the higher costs of serious SSIs at the upper end of the cost distribution are consistent with increased costs because of additional surgery and hospital length of stay.
Our study has a number of strengths and unique features. We used quantile regression to assess the difference in economic impact of serious and nonserious SSIs across the distribution of overall health care costs. Standard analyses often use OLS models that only assess mean costs and assume that costs are normally distributed, and that infections impact costs similarly across the cost distribution. Our findings show that models based on differences in mean costs may be insufficient to describe costs due to SSIs and that costs vary depending on the severity of infection. Quantile regression is an infrequently used econometric technique that may have broader applicability in studies of health care costs. 22, [25] [26] [27] [28] We used a rich data source that contained information across the spectrum of care from inpatient hospitalizations to outpatient clinic visits and prescriptions. We were able to include all documented infections regardless of site of care rather than only the subset of infections identified at re-admission to the hospital where the index procedure was performed. We also included procedures performed at freestanding ASCs and outpatient surgeries at a hospital. This is very important given the increasing utilization of outpatient surgery for all 4 of the surgical procedures analyzed.
Our study had several limitations. Coding errors may have resulted in misclassification of other complications as infection. In addition, the sensitivity of ICD-9-CM diagnosis codes to identify SSIs is imperfect, particularly for minor outpatient infections during the 90-day global period for physician reimbursement. The effect of this misclassification would have resulted in underdetection of minor SSIs, and thus our estimates for the attributable costs of nonserious SSIs may overestimate the true costs. The reduced sensitivity to identify nonserious SSIs should not have had significant impact on the calculation of costs attributable to serious infections, because serious SSIs treated in the outpatient setting would be more likely to be coded owing to reimbursement of wound care procedures (even in the global reimbursement period), and the sensitivity and positive predictive values of the ICD-9-CM diagnosis codes we used to identify SSIs diagnosed and treated during inpatient hospitalizations are relatively high. [29] [30] [31] We adjusted for many factors related to both SSI and medical costs in the quantile regression models, but there may still be residual confounding due to omitted variables (ie, endogeneity). Although the claims database is large and geographically dispersed, all patients have private insurance and our findings may not be generalizable to patients with other types of insurance in the US or other countries.
SSIs, especially serious infections resulting in hospitalization or surgical treatment, were associated with significantly increased health care costs after 4 common surgical procedures. Quantile regression illustrated the impact of serious SSIs on health care costs across the distribution of costs, especially at the upper end of the cost distribution. This study demonstrates the additional information on health care costs that can be obtained by quantile regression modeling and supports use of this method to quantify attributable costs of hospital-acquired infections. 
